Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:55:52.000Z thumbnail image
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the data related to a study of Venetoclax and Dinaciclib in patients with relapsed/refractory Acute Myeloid Leukemia. This change may be significant for individuals monitoring medical and healthcare-related publications and documentation.
    Difference
    0.1%
    Check dated 2024-06-06T14:49:53.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments. Additionally, it now includes a link for general information about clinical research.
    Difference
    16%
    Check dated 2024-05-22T21:34:30.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:49:25.000Z thumbnail image

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.